2021 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar
2021 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar
批准号:
10217714
负责人:
Daniel J. Tschumperlin
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-10 至 2022-05-31
关键词:
AddressAreaAsthmaAutomobile DrivingBiologicalBiologyBiomedical EngineeringCOVID-19 pandemicCareer MobilityCellsCellular biologyCessation of lifeChronicChronic Obstructive Airway DiseaseChronic lung diseaseClinicalCollaborationsDataDevelopmentDiagnosisDisabled PersonsDiseaseEarly DiagnosisEnsureFacultyFosteringFundingGenderGeographyGrowthHealthInjuryInvestmentsLong COVIDLungLung diseasesMedicineMentorsMolecularMolecular BiologyPhysiciansPhysiologyPopulationPositioning AttributePostdoctoral FellowPulmonary FibrosisRaceResearchResearch PersonnelRoleSARS-CoV-2 infectionScientistSenior ScientistStructureTherapeuticTimeTissuesTranslatingTranslationsUnderrepresented MinorityViralWomanWorld Health Organizationcareercohortexperiencegraduate studenthuman diseaseinjury and repairknowledge integrationlung developmentlung injurymeetingsnext generationnovelpeerpeer networksprematurepulmonary functionrepairedrespiratoryrestorationsevere injurysymposiumtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
The 2021 Lung Development, Injury and Repair Gordon Research Conference (GRC) and associated Gordon
Research Seminar (GRS) will be held August 14-20, 2021 in Waterville Valley, NH. The theme for the 2021
Lung GRC is "Biological Discoveries to Transform Respiratory Medicine". This meeting comes at a critical time,
as the prolonged consequences of severe lung injuries associated with the COVID-19 pandemic will be coming
into focus, heightening our need to understand, and ultimately counteract, the dysfunctional repair and
remodeling that follows severe injury. Moreover, the growing global burden of lung disease continues
unabated, with some 4 million premature deaths annually worldwide attributed to chronic respiratory diseases,
including COPD, asthma, and pulmonary fibrosis, according to the World Health Organization. While
investments in basic scientific research continue to accelerate substantial strides forward in understanding
molecular, cellular and tissue level mechanisms driving respiratory diseases, translation of these findings
toward early detection and effective repair and restoration of lung function in chronic respiratory diseases
remains a major barrier. Meeting this challenge requires the integration of knowledge from experts spanning
lung development, molecular and cell biology, physiology, bioengineering, matrix biology as well as physicians
and translational experts immersed in the diagnosis and treatment of human disease. This conference will
bring this diversity of expertise together to disseminate and debate the latest findings in the fields of lung
development, injury and repair, and to formulate the new ideas, collaborations and approaches that will be
needed to translate biologic discoveries toward meaningful advances in respiratory medicine. A major
emphasis of the Lung GRC and GRS is to strengthen the pipeline of scientists and clinicians focused on lung
development, injury and repair. Funds from this R13 will be specifically targeted to promote participation in the
conference by women, under-represented minorities and people with disabilities, particularly graduate
students, postdoctoral fellows, and early career investigators. The unique attributes of the GRC (small,
secluded, unpublished data, abundant time for discussion) and GRS (close trainee interactions with peers and
seniors) formats provide an opportunity for formal and informal interactions and collaborations that are likely to
have significant and sustained impact on the field. The Lung Development, Injury and Repair GRC/GRS will
thus promote accelerated progress in understanding and treating chronic lung diseases, and help to ensure the
vitality and growth of a diverse pipeline of clinicians and scientists capable of addressing the growing burden of
lung diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fibrogenic activation and memory in the lung mesenchyme
-
批准号:10558822
-
项目类别:
-
资助金额:$59.6万
-
财政年份:2022
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.
-
批准号:10530660
-
项目类别:
-
资助金额:$63.32万
-
财政年份:2020
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.
-
批准号:10318078
-
项目类别:
-
资助金额:$61.97万
-
财政年份:2020
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices.
-
批准号:10025548
-
项目类别:
-
资助金额:$48.68万
-
财政年份:2020
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Matrix remodeling in microfluidic co-culture
-
批准号:9087443
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2016
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Screening Fibroblast-Matrix Stiffness Interactions to ID New Fibrosis Therapies
-
批准号:8445051
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2013
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Screening Fibroblast-Matrix Stiffness Interactions to ID New Fibrosis Therapies
-
批准号:8712545
-
项目类别:
-
资助金额:$19.48万
-
财政年份:2013
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:7729005
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:10390336
-
项目类别:
-
资助金额:$56.66万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Epithelial-Mesenchymal Interactions in Fibrosis Resolution
-
批准号:10655172
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:9906248
-
项目类别:
-
资助金额:$56.95万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:9757559
-
项目类别:
-
资助金额:$59.15万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:8118066
-
项目类别:
-
资助金额:$41.31万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:7907679
-
项目类别:
-
资助金额:$41.31万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:9187038
-
项目类别:
-
资助金额:$40.53万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:10160943
-
项目类别:
-
资助金额:$56.79万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Mechanobiology of Lung Fibrosis
-
批准号:8307788
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2009
-
负责人:Daniel J. Tschumperlin
-
依托单位:
A microrheometric assay of matrix mechanics
-
批准号:7030750
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2006
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Transduction of the environment in airway epithelium
-
批准号:7017371
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2006
-
负责人:Daniel J. Tschumperlin
-
依托单位:
Molecular transduction of the mechanical environment in airway epithelium
-
批准号:7164424
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2006
-
负责人:Daniel J. Tschumperlin
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: